AKT1 and liver cancer: Importantly, the genes that were differentially expressed in both CMT- and CMT + sgTP53-transformed iHeps compared to fibroblasts showed a clear and significant positive enrichment for the previously reported “subclass 2” liver cancer signature [52], associated with proliferation and activation of the MYC and AKT signaling pathways (Fig. 5A).